Key Events This Week
31 Aug: Stock opens at Rs.4,137.90, down 1.80%
01 Sep: Death Cross formation signals bearish trend
02 Sep: Technical downgrade to Sell rating amid bearish momentum
04 Sep: Week closes at Rs.4,219.35, up 0.14% for the week
Sep 23, 11:22 AM
BSE+NSE Vol: 766
Sanofi Consumer Healthcare India Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The company’s Mojo Grade was downgraded from Hold to Sell on 10 August 2026, reflecting deteriorating market sentiment and technical weakness amid a challenging pharmaceutical sector backdrop.
Read full news articleSanofi Consumer Healthcare India Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, with recent indicators signalling a predominantly bearish outlook despite some pockets of bullishness. The stock’s current price stands at ₹4,003.95, reflecting a slight decline of 0.30% on 22 Sep 2026, as it navigates a challenging market environment marked by mixed technical signals and underperformance relative to benchmark indices.
Read full news articleSanofi Consumer Healthcare India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 10 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 September 2026, providing investors with the latest insights into its performance and outlook.
Read full news article
31 Aug: Stock opens at Rs.4,137.90, down 1.80%
01 Sep: Death Cross formation signals bearish trend
02 Sep: Technical downgrade to Sell rating amid bearish momentum
04 Sep: Week closes at Rs.4,219.35, up 0.14% for the week
Sanofi Consumer Healthcare India Ltd is rated Sell by MarketsMOJO. This rating was last updated on 10 August 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 02 September 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news articleSanofi Consumer Healthcare India Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The company’s recent downgrade from a Hold to a Sell rating reflects deteriorating price action and weakening market sentiment amid broader sector challenges.
Read full news articleSanofi Consumer Healthcare India Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average (DMA) crosses below the 200-DMA, signalling a potential shift towards a prolonged bearish trend. This development highlights deteriorating momentum and raises concerns about the stock’s near- and long-term outlook amid already challenging market conditions.
Read full news articleSanofi Consumer Healthcare India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 10 August 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 22 August 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news articleSanofi Consumer Healthcare India Ltd has experienced a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bearish stance. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, reflecting a complex outlook for the pharmaceuticals and biotechnology small-cap stock.
Read full news articleCopy of Newspaper Publication of Unaudited Financial Results for the quarter and half year ended 30th June 2026 is enclosed.
We wish to inform you that the Board of Directors at its meeting held today i.e. Tuesday 28th July 2026 inter alia considered and approved the Unaudited Financial Results for the quarter and half year ended 30th June 2026.
The Board of Directors at its meeting held on Tuesday 28th July 2026 considered and approved the Unaudited Financial Results for the quarter and half year ended 30th June 2026. In this regard please find enclosed a press release.
No Upcoming Board Meetings
Sanofi Consumer Healthcare India Ltd has declared 750% dividend, ex-date: 19 Jun 26
No Splits history available
No Bonus history available
No Rights history available